Skip to main content

Table 4 Performance matrix of predictive model of disease progression in patients to be treated with ICI monotherapy regimens

From: Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

 

Predicted non-progressor

Predicted progressor

Indeterminate

Observed non-progressor

19

1

3

Observed Progressor

1

11

5

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us